Inflammatory Response Cells During Acute Respiratory Distress Syndrome in Patients With Coronavirus Disease 2019 (COVID-19).
作者信息
Zhang Yulin, Gao Yuxue, Qiao Luxin, Wang Wenjing, Chen Dexi
机构信息
Beijing Institute of Hepatology, Beijing You An Hospital, Capital Medical University, Beijing, China (Y.Z., Y.G., L.Q., W.W., D.C.).
出版信息
Ann Intern Med. 2020 Sep 1;173(5):402-404. doi: 10.7326/L20-0227. Epub 2020 Apr 13.
Abstract
摘要
相似文献
1
Inflammatory Response Cells During Acute Respiratory Distress Syndrome in Patients With Coronavirus Disease 2019 (COVID-19).2019冠状病毒病（COVID-19）患者急性呼吸窘迫综合征期间的炎症反应细胞
Ann Intern Med. 2020 Sep 1;173(5):402-404. doi: 10.7326/L20-0227. Epub 2020 Apr 13.
2
Coronavirus in China.中国的冠状病毒。
Lancet Respir Med. 2020 Mar;8(3):238. doi: 10.1016/S2213-2600(20)30056-4. Epub 2020 Feb 3.
3
Diabetes and severity of COVID-19: What is the link?糖尿病与 COVID-19 严重程度：二者有何关联？
Med Hypotheses. 2020 Oct;143:109923. doi: 10.1016/j.mehy.2020.109923. Epub 2020 May 30.
4
Mesenchymal Stem Cell Therapy Can Transcend Perianal Crohn's Disease: How Colorectal Surgeons Can Help in the Coronavirus Disease 2019 Crisis.间充质干细胞疗法可超越肛周克罗恩病：结直肠外科医生如何在2019冠状病毒病危机中提供帮助。
Dis Colon Rectum. 2020 Jul;63(7):874-878. doi: 10.1097/DCR.0000000000001700.
5
Phenotypical and functional alteration of unconventional T cells in severe COVID-19 patients.在重症 COVID-19 患者中非常规 T 细胞的表型和功能改变。
J Exp Med. 2020 Dec 7;217(12). doi: 10.1084/jem.20200872.
6
P-selectin blockade in COVID-19-related ARDS.新冠病毒相关急性呼吸窘迫综合征中P-选择素的阻断作用
Am J Physiol Lung Cell Mol Physiol. 2020 Jun 1;318(6):L1237-L1238. doi: 10.1152/ajplung.00202.2020.
7
Heterogeneity of Acute Respiratory Distress Syndrome in COVID-19: "Typical" or Not?新型冠状病毒肺炎中急性呼吸窘迫综合征的异质性：是否为“典型”？
Am J Respir Crit Care Med. 2020 Aug 15;202(4):618-619. doi: 10.1164/rccm.202004-1106LE.
8
Severe Acute Respiratory Syndrome-Coronavirus-2 Infection and Patients With Lung Cancer: The Potential Role of Interleukin-17 Target Therapy.严重急性呼吸综合征冠状病毒 2 感染和肺癌患者：白细胞介素 17 靶向治疗的潜在作用。
J Thorac Oncol. 2020 Jul;15(7):e101-e103. doi: 10.1016/j.jtho.2020.04.015. Epub 2020 Apr 27.
9
Establishing a Unified COVID-19 "Immunome": Integrating Coronavirus Pathogenesis and Host Immunopathology.建立统一的新冠病毒“免疫组”：整合冠状病毒发病机制与宿主免疫病理学
Front Immunol. 2020 Jul 3;11:1642. doi: 10.3389/fimmu.2020.01642. eCollection 2020.
10
A brewing storm: The neuropsychological sequelae of hyperinflammation due to COVID-19.一场蓄势待发的风暴：COVID-19引发的过度炎症反应的神经心理学后遗症
Brain Behav Immun. 2020 Aug;88:957-958. doi: 10.1016/j.bbi.2020.06.008. Epub 2020 Jun 23.
引用本文的文献
1
Is Altered Surfactant Protein Gene Expression in Peripheral Blood Associated with COVID-19 Disease Severity?外周血中表面活性蛋白基因表达的改变与新冠病毒疾病严重程度相关吗？
Diagnostics (Basel). 2025 Jul 2;15(13):1690. doi: 10.3390/diagnostics15131690.
2
COVID-19 Vaccination and Disease Course in People with Multiple Sclerosis in Greece.希腊多发性硬化症患者的新冠疫苗接种与病程
J Clin Med. 2023 Aug 23;12(17):5460. doi: 10.3390/jcm12175460.
3
What do we know about IL-6 in COVID-19 so far?到目前为止，我们对新冠病毒中的白细胞介素-6了解多少？
Biophys Rep. 2021 Jun 30;7(3):193-206. doi: 10.52601/bpr.2021.200024.
4
Age and Comorbidities Predict COVID-19 Outcome, Regardless of Innate Immune Response Severity: A Single Institutional Cohort Study.年龄和合并症可预测新冠病毒疾病的预后，与先天免疫反应严重程度无关：一项单机构队列研究
Crit Care Explor. 2022 Dec 5;4(12):e0799. doi: 10.1097/CCE.0000000000000799. eCollection 2022 Dec.
5
Cell deaths: Involvement in the pathogenesis and intervention therapy of COVID-19.细胞死亡：在 COVID-19 发病机制和干预治疗中的作用。
Signal Transduct Target Ther. 2022 Jun 13;7(1):186. doi: 10.1038/s41392-022-01043-6.
6
Postmortem high-dimensional immune profiling of severe COVID-19 patients reveals distinct patterns of immunosuppression and immunoactivation.COVID-19 重症患者死后高维免疫特征分析揭示了不同的免疫抑制和免疫激活模式。
Nat Commun. 2022 Jan 12;13(1):269. doi: 10.1038/s41467-021-27723-5.
7
Using Imaging Mass Cytometry to Define Cell Identities and Interactions in Human Tissues.利用成像质谱流式细胞术定义人体组织中的细胞身份和相互作用。
Front Physiol. 2021 Dec 22;12:817181. doi: 10.3389/fphys.2021.817181. eCollection 2021.
8
Immune Profile and Clinical Outcome of Breakthrough Cases After Vaccination With an Inactivated SARS-CoV-2 Vaccine.接种灭活 SARS-CoV-2 疫苗后突破性病例的免疫特征和临床结局。
Front Immunol. 2021 Sep 29;12:742914. doi: 10.3389/fimmu.2021.742914. eCollection 2021.
9
Epigenetic targeting of the ACE2 and NRP1 viral receptors limits SARS-CoV-2 infectivity.表观遗传学靶向 ACE2 和 NRP1 病毒受体可限制 SARS-CoV-2 感染性。
Clin Epigenetics. 2021 Oct 11;13(1):187. doi: 10.1186/s13148-021-01168-5.
10
Effect of ORF7 of SARS-CoV-2 on the Chemotaxis of Monocytes and Neutrophils In Vitro.SARS-CoV-2 的 ORF7 对体外单核细胞和中性粒细胞趋化性的影响。
Dis Markers. 2021 Sep 28;2021:6803510. doi: 10.1155/2021/6803510. eCollection 2021.
本文引用的文献
1
Pathological findings of COVID-19 associated with acute respiratory distress syndrome.与急性呼吸窘迫综合征相关的新型冠状病毒肺炎的病理表现
Lancet Respir Med. 2020 Apr;8(4):420-422. doi: 10.1016/S2213-2600(20)30076-X. Epub 2020 Feb 18.
2
The clinical pathology of severe acute respiratory syndrome (SARS): a report from China.严重急性呼吸综合征（SARS）的临床病理学：来自中国的报告。
J Pathol. 2003 Jul;200(3):282-9. doi: 10.1002/path.1440.
3
Lung pathology of fatal severe acute respiratory syndrome.重症急性呼吸综合征致死病例的肺部病理改变
Lancet. 2003 May 24;361(9371):1773-8. doi: 10.1016/s0140-6736(03)13413-7.
Zotero 插件